tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

RNXT Stock Latest News

RenovoRx announces new clinical data on TAMP therapy platform
The FlyRenovoRx announces new clinical data on TAMP therapy platform
4h ago
RNXT
RenovoRx initiated with a Buy at JonesResearch
PremiumThe Fly
RenovoRx initiated with a Buy at JonesResearch
6d ago
RNXT
RenovoRx expands RenovoCath commercial adoption to nine cancer centers
PremiumThe Fly
RenovoRx expands RenovoCath commercial adoption to nine cancer centers
15d ago
RNXT
RenovoRx to announce new clinical data from Phase III TIGeR-PaC trial
PremiumThe Fly
RenovoRx to announce new clinical data from Phase III TIGeR-PaC trial
27d ago
RNXT
RenovoRx Receives Nasdaq Notice for Bid Price Noncompliance
PremiumCompany Announcements
RenovoRx Receives Nasdaq Notice for Bid Price Noncompliance
1M ago
8K
RNXT
Strategic Expansion and Promising Clinical Results Justify Buy Rating for RenovoRx
PremiumRatingsStrategic Expansion and Promising Clinical Results Justify Buy Rating for RenovoRx
3M ago
RNXT
RenovoRx’s Innovative Cancer Treatment and Promising Phase 3 Study Drive Buy Rating
Premium
Ratings
RenovoRx’s Innovative Cancer Treatment and Promising Phase 3 Study Drive Buy Rating
3M ago
RNXT
RenovoRx Earnings Call: Positive Momentum and Strategic Growth
Premium
Company Announcements
RenovoRx Earnings Call: Positive Momentum and Strategic Growth
3M ago
RNXT
RenovoRx Enters Capital on Demand Sales Agreement
PremiumCompany Announcements
RenovoRx Enters Capital on Demand Sales Agreement
3M ago
8K
RNXT
RenovoRx files $50M mixed securities shelf
PremiumThe Fly
RenovoRx files $50M mixed securities shelf
3M ago
RNXT
RenovoRx price target lowered to $3 from $3.50 at Alliance Global
PremiumThe Fly
RenovoRx price target lowered to $3 from $3.50 at Alliance Global
3M ago
RNXT
RenovoRx Reports Q3 2025 Earnings and Business Growth
PremiumCompany Announcements
RenovoRx Reports Q3 2025 Earnings and Business Growth
3M ago
RNXT
RenovoRx Expands Reach with RenovoCath Approval
PremiumCompany AnnouncementsRenovoRx Expands Reach with RenovoCath Approval
3M ago
8K
RNXT
RenovoRx reports Q3 EPS (8c), two estimates (8c)
Premium
The Fly
RenovoRx reports Q3 EPS (8c), two estimates (8c)
3M ago
RNXT
Is RNXT a Buy, Before Earnings?
Premium
Pre-Earnings
Is RNXT a Buy, Before Earnings?
3M ago
RNXT
RenovoRx appoints Timothy Donahue to Strategic Advisory Board
PremiumThe Fly
RenovoRx appoints Timothy Donahue to Strategic Advisory Board
3M ago
RNXT
RenovoRx’s PanTheR Registry Trial: A New Frontier in Tumor Treatment
PremiumCompany Announcements
RenovoRx’s PanTheR Registry Trial: A New Frontier in Tumor Treatment
3M ago
RNXT
RenovoRx’s Innovative Approach in Pancreatic Cancer Treatment: A Clinical Study Update
PremiumCompany Announcements
RenovoRx’s Innovative Approach in Pancreatic Cancer Treatment: A Clinical Study Update
3M ago
RNXT
RenovoRx expands Scientific Advisory Board with appointment of Baere
PremiumThe Fly
RenovoRx expands Scientific Advisory Board with appointment of Baere
4M ago
RNXT
RenovoRx announces first patient procedure completed in PanTheR study
PremiumThe FlyRenovoRx announces first patient procedure completed in PanTheR study
4M ago
RNXT
RenovoRx’s Earnings Call: Positive Outlook Amid Growth
Premium
Company Announcements
RenovoRx’s Earnings Call: Positive Outlook Amid Growth
5M ago
RNXT
Buy Rating Affirmed for RenovoRx Amid Promising Phase 3 Study Progress and Potential Stock Catalyst
Premium
Ratings
Buy Rating Affirmed for RenovoRx Amid Promising Phase 3 Study Progress and Potential Stock Catalyst
6M ago
RNXT

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >